Advanced Containment Solution for Potent APIs and High-Sensitivity Products
The pharmaceutical industry’s demand for stringent safety standards and regulatory compliance continues to grow, especially when dealing with potent active pharmaceutical ingredients (APIs) and high-sensitivity products. To address this need, the Isolator-Compatible Granulation Line provides an advanced containment solution that ensures both operator safety and product integrity throughout the manufacturing process.
Overview of the Isolator-Compatible Granulation Line
Our Isolator-Compatible Granulation Line represents the latest innovation in contained granulation technology, specifically designed for pharmaceutical manufacturers. This state-of-the-art system is engineered to meet the highest containment standards (OEL) while supporting the production of potent APIs. Its turnkey design seamlessly fits into a single isolator chamber, incorporating a range of processes from sieving to final blending—all contained within an enclosed environment to prevent any product exposure to the operators.
Key Features of the Isolator-Compatible Granulation Line
Complete Integrated Granulation Line
The Isolator-Compatible Granulation Line includes a fully integrated system of equipment that meets the diverse needs of pharmaceutical manufacturers. The system comprises a Sifter, Rapid Mixer Granulator (RMG), Fluid Bed Dryer (FBD), Cone Mill, and Blender, all of which are housed within the isolator. This integration ensures minimal operator exposure while offering maximum protection for the product. The enclosed environment also maintains clean conditions, safeguarding the final product’s quality and preventing contamination.
Flexible Batch Capacities
One of the most important features of this granulation line is its flexibility. The system is customizable, with batch capacities ranging from 1 kg to 15 kg per batch. This adaptability ensures that manufacturers can efficiently scale production according to their specific needs, whether they are dealing with small clinical batches or larger commercial production volumes.
Wash-In-Place (WIP) Compatibility
A crucial component of any containment system is the ease with which it can be cleaned. The Isolator-Compatible Granulation Line incorporates Wash-In-Place (WIP) systems, allowing for efficient and safe cleaning without breaking containment. The WIP system ensures that the entire production process can be sterilized quickly and thoroughly, reducing downtime and maintaining high standards of cleanliness between batches.
High-Integrity Sealing System
To maintain the integrity of the containment system, specialized seals are incorporated into the working zones of the isolator. These seals prevent any particulate leakage, ensuring that the granulation process remains fully contained. This high-integrity sealing system is crucial for maintaining both operator safety and product protection during the entire manufacturing process.
Advanced Air Filtration
Air filtration is another essential feature in maintaining a controlled environment for both operators and products. The Isolator-Compatible Granulation Line includes air filtration up to 0.3 microns, which ensures that the air within the isolator remains free from contaminants. This advanced filtration system plays a vital role in protecting the product from ambient contaminants and ensuring that the final product meets the highest quality standards.
Automated Control System
The Isolator-Compatible Granulation Line comes with an automated PLC-based control system that is equipped with a Human-Machine Interface (HMI). This interface provides operators with intuitive control and real-time process monitoring, helping to streamline production while maintaining optimal safety and efficiency. The automated system also ensures that all production parameters are met consistently.
21 CFR Part 11 Compliance (Optional)
For pharmaceutical manufacturers seeking to meet FDA regulations, the Isolator-Compatible Granulation Line can be equipped with full 21 CFR Part 11 compliance. This ensures that the system adheres to FDA electronic record-keeping and electronic signature regulations, which is essential for ensuring regulatory compliance throughout the product lifecycle.
A Comprehensive Containment Solution for Potent Molecules
The Isolator-Compatible Granulation Line is part of a larger, integrated containment solution designed to handle the entire pharmaceutical manufacturing process for high-potency active pharmaceutical ingredients (HPAPIs). This system not only supports granulation but also encompasses critical operations such as sampling, dispensing, tablet compression, coating, and primary packaging. By consolidating all these steps into one enclosed, contained environment, the system helps minimize risks and maximize safety, compliance, and product integrity.
End-to-End Processing with Integrated Safety and Compliance
Our Isolator-Compatible Granulation Line offers a complete end-to-end processing solution that ensures all operations are carried out within a fully contained system. The solution covers a range of stages, including:
- Sampling & Dispensing: Safe handling of high-potency materials during the initial stages of production.
- Granulation: High shear mixing, pelletization, drying, and blending processes, all within a contained environment.
- Tablet Compression: Ensuring that potent APIs remain isolated throughout the tablet production process.
- Film Coating: Coating tablets with precision while maintaining containment.
- Primary Packaging: Safe packaging in blister, bottle, or strip formats, with minimal risk of exposure.
The Heart of the Solution: Granulation Isolator
At the core of our Isolator-Compatible Granulation Line is the Granulation Isolator, a specialized unit purpose-built to handle the complexities of high-potency materials. The isolator delivers:
- High-Level Containment: Ensuring maximum safety for operators by preventing exposure to potent compounds.
- Cross-Contamination Control: Maintaining a controlled and enclosed environment to avoid product contamination.
- Enhanced Product Integrity: Protecting the product’s quality by reducing contamination risks.
- Regulatory Compliance: Designed to meet international containment and cGMP standards, ensuring compliance with regulatory requirements in the U.S. and globally.
Conclusion
The Isolator-Compatible Granulation Line offers a cutting-edge solution for pharmaceutical manufacturers handling potent APIs and high-sensitivity products. By integrating advanced containment features, customizable batch capacities, and automated controls, this system ensures that production is safe, efficient, and fully compliant with the highest industry standards. Whether producing small clinical batches or scaling up to full commercial production, manufacturers can trust this all-in-one solution to deliver maximum safety, quality, and efficiency throughout the entire manufacturing lifecycle.
Director
Darshan Rao represents the new generation of leadership at Shree Bhagwati. As Director, he is committed to driving innovation, operational excellence, and growth across all facets of the company. With a focus on fostering strong relationships with stakeholders, partners, and clients, he leads a team of dedicated professionals in delivering high-quality manufacturing solutions.
One of his key strengths lies in pressure management—a crucial quality in the fast-paced and dynamic manufacturing industry. He firmly believes in turning challenges into opportunities and using adversity as a catalyst for growth and innovation.
To embark on this journey together, he invites you to join hands with Shree Bhagwati in pursuit of excellence, embracing innovation, and setting new benchmarks in manufacturing. Together, let us create a success story defined by integrity, ingenuity, and an unwavering commitment to quality.
